PMID- 29504283 OWN - NLM STAT- MEDLINE DCOM- 20191021 LR - 20191022 IS - 2192-2659 (Electronic) IS - 2192-2640 (Linking) VI - 7 IP - 13 DP - 2018 Jul TI - Graphene Materials in Antimicrobial Nanomedicine: Current Status and Future Perspectives. PG - e1701406 LID - 10.1002/adhm.201701406 [doi] AB - Graphene materials (GMs), such as graphene, graphene oxide (GO), reduced GO (rGO), and graphene quantum dots (GQDs), are rapidly emerging as a new class of broad-spectrum antimicrobial agents. This report describes their state-of-the-art and potential future covering both fundamental aspects and biomedical applications. First, the current understanding of the antimicrobial mechanisms of GMs is illustrated, and the complex picture of underlying structure-property-activity relationships is sketched. Next, the different modes of utilization of antimicrobial GMs are explained, which include their use as colloidal dispersions, surface coatings, and photothermal/photodynamic therapy agents. Due to their practical relevance, the examples where GMs function as synergistic agents or release platforms for metal ions and/or antibiotic drugs are also discussed. Later, the applicability of GMs in the design of wound dressings, infection-protective coatings, and antibiotic-like formulations ("nanoantibiotics") is assessed. Notably, to support our assessments, the existing clinical applications of conventional carbon materials are also evaluated. Finally, the key hurdles of the field are highlighted, and several possible directions for future investigations are proposed. We hope that the roadmap provided here will encourage researchers to tackle remaining challenges toward clinical translation of promising research findings and help realize the potential of GMs in antimicrobial nanomedicine. CI - (c) 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. FAU - Karahan, Huseyin Enis AU - Karahan HE AD - School of Chemical and Biomolecular Engineering, The University of Sydney, NSW, 2006, Australia. AD - School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, 637459, Singapore. AD - Singapore Institute of Manufacturing Technology, Singapore, 638075, Singapore. FAU - Wiraja, Christian AU - Wiraja C AD - School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, 637459, Singapore. FAU - Xu, Chenjie AU - Xu C AD - School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, 637459, Singapore. AD - NTU-Northwestern Institute of Nanomedicine, Nanyang Technological University, 50 Nanyang Avenue, Singapore, 639798, Singapore. FAU - Wei, Jun AU - Wei J AD - Singapore Institute of Manufacturing Technology, Singapore, 638075, Singapore. FAU - Wang, Yilei AU - Wang Y AD - School of Chemistry & Chemical Engineering, Tianjin University of Technology, 391 Binshui, Xidao, Xiqing District, Tianjin, 300384, China. FAU - Wang, Liang AU - Wang L AD - School of Chemistry & Chemical Engineering, Tianjin University of Technology, 391 Binshui, Xidao, Xiqing District, Tianjin, 300384, China. FAU - Liu, Fei AU - Liu F AD - State Key Laboratory of Applied Microbiology Southern China, Guangdong Provincial Key, Laboratory of Microbial Culture Collection and Application, Guangdong Institute of Microbiology, 100 Central Xianlie Road, Guangzhou, 510070, China. FAU - Chen, Yuan AU - Chen Y AUID- ORCID: 0000-0001-9059-3839 AD - School of Chemical and Biomolecular Engineering, The University of Sydney, NSW, 2006, Australia. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20180305 PL - Germany TA - Adv Healthc Mater JT - Advanced healthcare materials JID - 101581613 RN - 0 (Anti-Infective Agents) RN - 7782-42-5 (Graphite) SB - IM MH - Animals MH - Anti-Infective Agents/*chemistry/*pharmacology MH - *Bandages MH - Graphite/*chemistry MH - Humans MH - Nanomedicine/*methods MH - Structure-Activity Relationship MH - Wound Healing OTO - NOTNLM OT - antibacterial OT - clinical translation OT - graphene OT - implant coating OT - nanocarbon OT - wound dressing EDAT- 2018/03/06 06:00 MHDA- 2019/10/23 06:00 CRDT- 2018/03/06 06:00 PHST- 2017/12/01 00:00 [received] PHST- 2018/01/16 00:00 [revised] PHST- 2018/03/06 06:00 [pubmed] PHST- 2019/10/23 06:00 [medline] PHST- 2018/03/06 06:00 [entrez] AID - 10.1002/adhm.201701406 [doi] PST - ppublish SO - Adv Healthc Mater. 2018 Jul;7(13):e1701406. doi: 10.1002/adhm.201701406. Epub 2018 Mar 5.